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Wolfram syndrome, which is sometimes referred to as “DIDMOAD” (diabetes insipidus, diabetes mellitus, optic
atrophy, and deafness), is an autosomal recessive neurodegenerative disorder for which only insulin-dependent
diabetes mellitus and optic atrophy are necessary to make the diagnosis. Researchers have mapped Wolfram syn-
drome to chromosome 4p16.1, and, recently, a gene encoding a putative transmembrane protein has been cloned
and mutations have been identified in patients. To pursue the possibility of locus heterogeneity, 16 patients from
four different families were recruited. These patients, who have the Wolfram syndrome phenotype, also have
additional features that have not previously been reported. There is an absence of diabetes insipidus in all affected
family members. In addition, several patients have profound upper gastrointestinal ulceration and bleeding. With
the use of three microsatellite markers (D4S432, D4S3023, and D4S2366) reported to be linked to the chromosome
4p16.1 locus, we significantly excluded linkage in three of the four families. The two affected individuals in one
family showed homozygosity for all three markers from the region of linkage on chromosome 4p16.1. For the
other three families, genetic heterogeneity for Wolfram syndrome was verified by demonstration of linkage to
chromosome 4q22-24. In conclusion, we report the unique clinical findings and linkage-analysis results of 16
patients with Wolfram syndrome and provide further evidence for the genetic heterogeneity of this disorder. We
also provide data on a new locus that plays a role in the etiology of insulin-dependent diabetes mellitus.
Introduction
Wolfram syndrome, which is also known as “DID-
MOAD” (diabetes insipidus, diabetes mellitus, optic at-
rophy, and deafness [MIM 222300]) and which was first
described by Wolfram and Wagner (1938), is associated
with high morbidity and mortality. Only insulin-depen-
dent diabetes mellitus (IDDM) and progressive optic-
nerve atrophy (OA) are necessary to make the diagnosis,
but associated findings include sensorineural hearing loss
(SNHL), ataxia, peripheral neuropathy, urinary-tract at-
ony, and psychiatric illnesses (Rose et al. 1966; Cremers
et al. 1977; Swift et al. 1990; Salih and Tuvemo 1991).
Typically, but not invariably, IDDM is detected before
OA is detected, whereas diabetes insipidus (DI) and
SNHL may or may not develop. Wolfram syndrome is
an autosomal recessive disorder with probable locus
heterogeneity, based on reported clinical heterogeneity
(Rose et al. 1966; Page et al. 1976; Barrett and Bundey
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1997). The literature contains a wealth of familial and
individual reports as well as several comprehensive clin-
ical reviews (Bretz et al. 1970; Blasi et al. 1986; Kinsley
et al. 1995; Barrett and Bundey 1997).
Wolfram syndrome has previously been shown to be
linked to markers at chromosome 4p16.1 (Polymero-
poulos et al. 1994; Barrientos et al. 1996a, 1996b; Col-
lier et al. 1996). Recently, mutations in a gene known
as “wolframin” were identified in patients with Wolf-
ram syndrome (Inoue et al. 1998; Strom et al. 1998).
This gene, which encodes a novel protein containing
predicted transmembrane domains, is expressed ubiq-
uitously, with high expression in the pancreatic islets.
However, evidence of locus heterogeneity exists, in that
there was no linkage to this region in one small nuclear
family in which OA presented one decade prior to di-
abetes mellitus (DM), which is an atypical Wolfram syn-
drome phenotype (Collier et al. 1996).
In this study, we present clinical data on 16 affected
individuals with a clinical presentation that fits the di-
agnosis of Wolfram syndrome. These individuals are
from four consanguineous Jordanian families. The ge-
netic heterogeneity for Wolfram syndrome was verified
by mapping of another locus to chromosome 4q22-24,
by use of a DNA-pooling linkage strategy, and Neu-
romedin K receptor 3 (NKR3), a candidate gene that
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maps in the critical region, was screened for mutations
in patients with Wolfram syndrome.
Patients and Methods
Patient Evaluation
Nineteen individuals affected with Wolfram syndrome
were identified from seven families that were seen in the
clinical service provided by the National Center for Di-
abetes, Endocrine, and Genetic Diseases in Amman, Jor-
dan. Of these seven families, four families with several
affected siblings ( ) were recruited to participate inn = 16
the study after informed consent was obtained from each
individual or from a legal guardian. All recruited family
members were examined thoroughly, and detailed family
history and medical history were obtained. All available
family members underwent a detailed ophthalmologic
examination, and audiography was performed. Most of
those who showed signs of the disease also underwent
intravenous urography and magnetic-resonance imaging
of the pituitary gland. A water-deprivation test was done
for most family members. Any family member who
showed at least two of the four cardinal signs of Wolfram
syndrome was considered to be affected.
Genotyping and Linkage Analysis
DNA was extracted from leukocytes in venous blood,
by use of standard procedures. Four microsatellite DNA
markers (D4S432, D4S3023, D4S2366, and D4S2639)
known to be linked to the Wolfram syndrome locus on
chromosome 4p16.1 were used to test for linkage in the
four families (Polymeropoulos et al. 1994; Collier et al.
1996).
Homozygosity mapping was done with the use of a
DNA-pooling strategy (Sheffield et al. 1995). Equimolar
amounts of samples from families WS-3 and WS-4 were
independently pooled into affected and unaffected pools
from each family. Genotyping was performed by means
of standard protocols (Lidral et al. 1997).
A 20-cM genomewide scan was performed, with an
initial focus on those markers from the Weber mapping
panel, version 8.0 (Yuan et al. 1997), that are on gene-
rich chromosomes (Antonarakis 1994; Inglehearn
1997). Additional markers for fine mapping of the crit-
ical region were chosen from maps from the Center for
Medical Genetics, Marshfield Medical Research Foun-
dation (Broman et al. 1998), the Cooperative Human
Linkage Center (CHLC) (Murray et al. 1994), and
GeneMap’98 (Deloukas et al. 1998).
Two-point LOD score analysis was performed with
the use of the LINKAGE (Lathrop et al. 1984) and
GENEHUNTER (Kruglyak et al. 1996) programs, and
multipoint analysis was performed with the use of
GENEHUNTER, under the assumption of autosomal
recessive inheritance with 95% penetrance and a disease-
gene frequency of .005. The reference genetic map and
allele frequencies used for the analysis were generated
from CHLC and CEPH data (Broman et al. 1998). The
order and distances designated for the chromosome
4p16 markers were D4S432-.014-D4S3023-.0469-
DS2366-.205-D4S2639, and those designated for the
chromosome 4q markers were D4S3243-.051-D4S2361-
.114-D4S1647-.020-D4S1591-.021-D4S3256-.036-
D4S1531-.001-D4S1564-.014-D4S3240-.001-D4S26
23-.024-D4S2945-.128-D4S2394. Recalculation of
the LOD scores, by use of equal allele frequencies,
resulted in minimal changes and in no change in sig-
nificance (data not shown).
Mutation Screen
The NKR3 gene for was screened for mutations with
the use of primers designed to amplify the five exons,
including splice sites and splice-branch sites, (Buell et al.
1992; primer sequences available on request). Sequences
from one affected individual each from families WS-
2–WS-4, along with sequences from a control individual,
were sequenced with the use of the Big Dye Terminator
Cycle Sequencing Ready Reaction Kit (PE Biosystems)
and were analyzed on an ABI 310 capillary DNA ana-
lyzer (PE Biosystems). Templates were prepared by
means of PCR amplification and were purified with the
use of Qiaquick PCR columns (Qiagen).
Results
Clinical Features
Family WS-1.—The two affected individuals in family
WS-1 are a 17-year-old boy and a 10-year-old girl (table
1). Both presented with DM at the age of ∼5 years;
shortly thereafter, a visual deficit occurred in both, and
a hearing deficit occurred in the boy. The visual deficit
was attributed to progressive OA, whereas the hearing
loss was caused by high-frequency SNHL. The boy has
urinary-tract dilatation with impaired kidney function,
and both the boy and the girl had a normal response
(urine osmolarity doubled at the end of 3 h) to the water-
deprivation test. They both have soft, dysmorphic fea-
tures, probably as a result of decreased facial subcuta-
neous fat. Recently, after a severe chest infection, the
boy died of respiratory failure of central origin. The
parents in family WS-1 are first cousins (fig. 1).
Family WS-2.—Family WS-2 includes six affected in-
dividuals in one sibship (table 1; fig. 1). All affected
individuals had DM develop in the early part of their
second decade; this was soon followed by both visual
and hearing deficits, except in the case of the 20-year-
old man (individual V.9), who still has normal hearing.
All affected individuals have documented OA and high-
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Table 1
Diagnosis and Age at Diagnosis in Patients with Wolfram Syndrome
CHARACTERISTICS
DIAGNOSIS AND AGE AT DIAGNOSIS IN AFFECTED INDIVIDUALS IN EACH FAMILYa
Family
WS-1
Family
WS-2
Family
WS-3
Family
WS-4
IV.2 IV.4 V.1 V.2 V.6 V.7 V.9 V.13 V.3 V.8 V.9 V.10 IV.1 IV.2 IV.3 IV.4
Age (years) 17 10 38 35 25 23 20 15 28 14 14 14 14 12 12 6
Sex M F M F M F M F M M F F F F F F
DM: Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes No No No
Age at diagnosis (years) 5 5 15 15 12 14 15 12 10 10 10 10 13 NA NA NA
OA: Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes
Age at diagnosis (years) 7 7 20 22 18 18 19 14 20 12 12 12 13 11 11 5
SNHL: Yes No Yes Yes Yes Yes No Yes Yes Yes Yes Yes Yes Yes Yes Yes
Age at diagnosis (years) 10 NA 25 25 18 18 NA 14 24 12 12 12 13 11 11 5
DI No No No No No No No No No No No No No No No No
Urinary-tract dilatation: Yes No Yes Yes Yes No No No Yes Yes Yes No Yes No No No
Age at diagnosis (years) 14 NA 35 34 24 NA NA NA 24 12 12 NA 13 NA NA NA
Peptic ulcer: No No Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes No Yes No No
Age at diagnosis (years) NA NA 20 20 17 20 18 14 26 13 13 13 NA 11 NA NA
Diabetic retin No No Yes No Yes No No No Yes No No No No No No No
Status Dead Dead Alive Alive Alive Dead Alive Alive Alive Alive Alive Alive Alive Alive Alive Alive
a M = male; F = female; NA = not available.
frequency SNHL, and all have severe complicated pep-
tic-ulcer disease. They also all had a urine volume of !3
liters in 24 h. Individual V.6 had a normal response to
the water-deprivation test. The parents in this family are
distantly related (they are at least second cousins), and
they come from a very inbred family.
Family WS-3.—Family WS-3 includes naturally con-
ceived triplets that are affected with Wolfram syndrome
(table 1; fig. 1). Two additional members of this family
were suspected of having Wolfram syndrome, but they
were unavailable for study, since individual V.2 is living
abroad and since individual V.6 had died of a cause
unrelated to the disorder. The other four affected indi-
viduals all have DM that manifested when each indi-
vidual was ∼10 years old. They all have documented
OA and high-frequency SNHL. Three of the individuals
have urinary-tract dilatation, and one individual (V.3),
who was 28 years old at the time of the present study,
has end-stage renal failure. The triplets had a normal
response to the water-deprivation test. The parents are
second cousins.
Family WS-4.—Family WS-4 includes two affected
siblings and an affected monozygotic twin pair born to
parents who are first cousins (table 1; fig. 1). From a
previous marriage to a woman to whom he was not
related, the father has a daughter, who was age 16 years
at the time of the present study (data not shown). The
daughter presented with normal ophthalmologic find-
ings, normal fasting blood glucose levels, and no other
symptoms. The affected children include a girl (individ-
ual IV.1), who is currently 14 years old and who pre-
sented with DM at age 13 years. Although she had no
visual or hearing deficits, she has documented OA and
high-frequency SNHL. In addition, she has urinary-tract
dilatation with normal kidney function. The twins (in-
dividuals IV.2 and IV.3), who are currently 12 years old,
have documented and asymptomatic OA and high-fre-
quency SNHL . One of them had a high fasting blood
glucose level that later normalized. A girl (individual
IV.4), who is currently 6 years old, has documented and
asymptomatic OA and high-frequency SNHL. All af-
fected individuals in this family produced a urine volume
of !3 liters per 24 h with high osmolarity. The sisters
(individuals IV.5 and IV.6), who are 5 and 4 years old,
have optic nerves that appeared to be normal on oph-
thalmologic examination.
Excluding Linkage to the Chromosome 4p16 Locus
Linkage to the previously described Wolfram syn-
drome locus on chromosome 4p16 was explored by ge-
notyping of the markers D4S432, D4S3023, DS2366,
and D4S2639 in members of all four families. Visual
inspection revealed allelic heterozygosity for these mark-
ers in affected individuals from families WS-2–WS-4
(data not shown), whereas, affected individuals from
family WS-1 were found to be homozygous for markers
D4S432, D4S3023, D4S2366, and D4S2639 (fig. 1). For
family WS-1, the results of two-point linkage analysis
showed a maximum LOD score of 1.28 (table 1), and
multipoint linkage analysis indicated a maximum LOD
score of 1.87 near marker D4S3023 (data not shown).
Linkage to this region was excluded for families WS-
2–WS-4, each of which had a LOD score !2.0 (table 2).
Figure 1 Pedigrees of families with Wolfram syndrome (DIDMOAD). A, Family WS-1 shows homozygosity for markers at the chromosome
4p16 WFS1 locus. B–D, Families WS-2–WS-4 show haplotypes for markers at chromosome 4q22-24. Recombinations in individuals V.9 and
V.13 from family WS-2, individual IV.2 from family WS-3, and individual IV.1 from family WS-4 define the critical region. For individuals
denoted by an asterisk, genotypes were inferred from the genotypes of existing family members, and maximum-likelihood haplotypes were
deduced by use of GENEHUNTER. Blackened squares denote haplotypes and recombinants, and broken lines indicate alternative crossover
events that could also explain the data.
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Table 2
Two-Point LOD Scores between Wolfram Syndrome and
Chromosome 4p16 Markers
MARKER
LOD SCORE FOR
Family
WS-1
Family
WS-2
Family
WS-3
Family
WS-4
D4S432 1.28 2.49 2.57 3.95
D4S3023 .88 2.54 2.11 2.76
D4S2366 1.27 2.67 2.90 2.50
D4S2639 1.27 2.08 .63 NAa
a NA = Not available.
Table 3
Two-Point LOD Scores between Wolfram Syndrome and
Chromosome 4q Markers in Families WS-2, WS-3, and WS-4
LOD SCORE AT v =
LOCUS .0 .01 .05 .1 .2 .3 .4
D4S3243 1.48 1.22 .43 .07 .32 .21 .04
D4S2361 1.10 1.31 1.61 1.61 1.25 .72 .20
D4S1647 .67 .00 .42 .48 .37 .22 .08
D4S1591 2.10 1.41 .56 .09 .20 .18 .80
D4S3256 3.38 3.30 2.97 2.54 1.72 .96 .34
D4S1531 6.10 5.96 5.41 4.71 3.30 1.92 .68
D4S1564 6.84 6.70 6.11 5.35 3.82 2.31 .92
D4S3240 2.53 3.47 3.82 3.59 2.68 1.57 .53
D4S2623 2.21 3.10 3.32 3.08 2.29 1.40 .53
D4S2945 1.70 2.59 2.84 2.61 1.88 1.09 .39
D4S1651 2.85 3.74 3.90 3.56 2.58 1.51 .55
D4S2394 4.77 2.08 .19 .90 1.07 .77 .35
Linkage Mapping with the Use of Pooled DNA
Samples
Given the exclusion of linkage in three of the four
families, a 20-cM genomewide scan for additional loci
was performed with the use of a DNA-pooling strategy
for families WS-3 and WS-4. Approximately 30% of the
genome had been screened—initially, with the use of
markers from gene-rich chromosomes (Antonarakis
1994; Inglehearn 1997)—before homozygosity was
identified with the marker D4S1647 (data not shown).
The results of linkage analysis of additional markers
indicated a maximum two-point LOD score of 6.84 for
marker D4S1564, at recombination fraction (v) = 0
(table 3), and a multipoint maximum LOD score of 9.55
near markers D4S1531 and D4S1564 (fig. 2). Recom-
binations in individuals V.9 and V.13 in family WS-2,
individual IV.2 in family WS-3, and individual IV.1 in
family WS-4 defined the critical region as a 7.1-cM re-
gion between D4S1591 and D4S3240 (fig. 1). Haplotype
analysis revealed a common haplotype for markers
D4S3256, D4S1531, and D4S1564 in members of all
three families, suggesting that they may have a common
ancestor.
Mutation Screen of the NKR3 Gene
The NKR3 gene, which has been mapped near
D4S411 and D4S3256 on GeneMap’98, was screened
for mutations, since it is expressed in the brain and kid-
ney and since it is involved in the regulation of neuro-
transmission, inflammation, and pain sensation (Buell et
al. 1992). Sequencing of the five exons of the NKR3
gene did not indicate any coding or splicing mutations
in affected individuals from families WS-2–WS-4.
Discussion
In the present study, the clinical symptoms of the affected
members of four families demonstrate phenotypic het-
erogeneity, since DI was not diagnosed in any individual,
although it was suspected in a few. The method (urine
volume) used for diagnosis of DI is not the most accu-
rate, but several patients underwent the water-depriva-
tion test. Even if milder forms of DI exist, it is definitely
less common than has been reported in previous series
(Bretz et al. 1970). In family WS-1, onset of DM and
OA occurred at an earlier age than it did in families WS-
2–WS-4. Also, in family WS-1, the morbidity of the dis-
ease is more severe, resulting in early mortality. Patients
from families WS-2 and WS-3 seem to have an unusual
peptic-ulcer disease that has not previously been re-
ported in patients with Wolfram syndrome. This finding
is currently undergoing further study. DM was diag-
nosed in all affected individuals, with the exception of
the three younger siblings from family WS-4, who pre-
sented with OA and SNHL (table 1). This is not the
typical sequence of clinical symptoms; however, OA has
been the initial presentation in other clinical series (Bar-
rett and Bundey 1997).
Homozygosity mapping by means of a DNA-pooling
strategy and subsequent linkage analysis successfully lo-
cated the presence of another locus for Wolfram syn-
drome, WFS2, to a 7.1-cM region between D4S1591
and D4S3240. Previously, the NKR3 gene had been
mapped to this interval. However, mutation analysis of
the five coding exons did not reveal any mutations, thus
excluding NKR3 as a gene for Wolfram syndrome.
Within the WFS2 critical region, 22 genes have been
mapped, in addition to multiple expressed sequence
tags, which will be the basis for positional-cloning
efforts.
The pathology of Wolfram syndrome has been spec-
ulated to be a result of nuclear mutations that cause
deletions in the mitochondrial genome, and a semidom-
inant model of inheritance, in which heterozygous car-
riers are at greater risk for these deletions and may
manifest some of the clinical features of Wolfram syn-
drome, has been proposed (Barrientos et al. 1996a,
1996b). A high frequency of mitochondrial deletions
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Figure 2 Multipoint LOD plot for markers in the chromosome 4q22-24 region of families WS-2–WS-4
has been found in the CNS tissue of one patient (Bar-
rientos et al. 1996b). However, studies of lymphocytes
have been variable, ranging from no deletions (Barret
et al. 1997) to a low frequency of deletions (Rotig et
al. 1993; Barrientos et al. 1996a, 1996b). In addition,
neither the tRNALeu(3243) mutation associated with mi-
tochondrial DM nor the mitochondrial deletions have
been found in other studies of patients with Wolfram
syndrome (Hofmann et al. 1997; Strom et al. 1998;
Hardy et al. 1999), thereby leading researchers to ques-
tion the role of mitochondrial genome anomalies in the
etiology of Wolfram syndrome. It has been suggested
that the wolframin gene may be a mitochondrial
membrane protein and that mutations may affect mi-
tochondrial function, although not through effects on
the mitochondrial genome (Strom et al. 1998). Subcel-
lular localization of Wolframin and identification of the
WFS2 gene will help discern the role of the mitochon-
dria in the pathophysiology of Wolfram syndrome.
Mapping of Wolfram syndrome loci may provide in-
formation regarding more common psychiatric and di-
abetic diseases. Given that the carrier frequency is es-
timated to be 1/350 (Barrett and Bundey 1997), carriers
may contribute to a significant frequency of psychiatric
illness and diabetes. The majority of patients with Wolf-
ram syndrome have been shown to have had a history
of psychiatric illness, including severe depression, psy-
chosis, or organic brain syndrome (Swift et al. 1990).
In addition, heterozygous carriers have a 26-fold in-
crease in risk for psychiatric illness (Swift et al. 1998).
Bipolar disorder, which is among a variety of psychiatric
disorders that have been mapped to chromosome 4
(Kennedy et al. 1999), shows weak linkage to marker
D4S1647, which maps to a location 5 cM proximal to
the WFS2 region (Detara-Wadleigh et al. 1997). Also,
weak linkage for schizophrenia exists at marker
D4S2623 (Levinson et al. 1998), with a recent report
showing suggestive linkage to D4S2917 (reviewed by
Kennedy et al. 1999). D4S2917 is within the WFS2
critical region, and D4S2623 is very close to the distal
critical region. Susceptibility loci for bipolar disorder
have also been mapped to markers flanking the WFS1
locus on chromosome 4p16 (Blackwood et al. 1996;
Ginns et al. 1998; reviewed by Kennedy et al. 1999),
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further supporting a possible role for Wolfram syn-
drome genes in the etiology of mental illness.
Heterozygous carriers of WFS1 also have an increased
risk for DM (Ohata et al. 1998). A locus contributing
to insulin activity has been mapped near fatty acid–
binding protein 2 (FABP2) in Pima Indians (Prochazka
et al. 1993) and Mexican Americans (Mitchell et al.
1995). FABP2 maps to markers flanking the distal as-
pect of the WFS2 critical region. This mapping is in the
same region that shows suggestive linkage for type 2
DM in Mexican Americans (Duggirala et al. 1999).
Weak linkage of IDDM to D4S1604, which maps 30
cM distal to the WFS2 critical region, has previously
been reported (Hashimoto et al. 1994). Thus, cloning
of the WFS2 gene may provide an understanding of
diabetes and psychiatric disorders, in addition to pro-
viding a further understanding of the pathophysiology
of Wolfram syndrome.
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